Tibet Weixinkang Medicine Co., Ltd. (603676.SS)
CNY 10.26
(-1.25%)
CNY 10.26
(-1.25%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.50 CNY | 21.95% |
| 2022 | 0.41 CNY | 78.26% |
| 2021 | 0.23 CNY | 64.29% |
| 2020 | 0.14 CNY | 7.69% |
| 2019 | 0.13 CNY | -23.53% |
| 2018 | 0.17 CNY | -34.62% |
| 2017 | 0.26 CNY | -18.75% |
| 2016 | 0.32 CNY | -48.39% |
| 2015 | 0.62 CNY | -98.78% |
| 2014 | 50.83 CNY | 10950.0% |
| 2013 | 0.46 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.22 CNY | 2371.91% |
| 2024 Q2 | 0.16 CNY | -27.27% |
| 2024 Q3 | 0.18 CNY | 12.5% |
| 2023 Q2 | 0.17 CNY | 21.43% |
| 2023 FY | - CNY | 21.95% |
| 2023 Q1 | 0.14 CNY | 131.4% |
| 2023 Q4 | 0.01 CNY | -95.06% |
| 2023 Q3 | 0.18 CNY | 5.88% |
| 2022 Q4 | 0.06 CNY | -45.0% |
| 2022 FY | - CNY | 78.26% |
| 2022 Q3 | 0.11 CNY | -26.67% |
| 2022 Q2 | 0.15 CNY | 63.04% |
| 2022 Q1 | 0.09 CNY | 187.5% |
| 2021 Q2 | 0.08 CNY | 87.5% |
| 2021 FY | - CNY | 64.29% |
| 2021 Q4 | 0.03 CNY | -48.88% |
| 2021 Q1 | 0.04 CNY | 19.4% |
| 2021 Q3 | 0.06 CNY | -16.53% |
| 2020 Q1 | 0.03 CNY | -8.81% |
| 2020 FY | - CNY | 7.69% |
| 2020 Q4 | 0.03 CNY | -16.25% |
| 2020 Q3 | 0.04 CNY | -14.53% |
| 2020 Q2 | 0.05 CNY | 56.0% |
| 2019 FY | - CNY | -23.53% |
| 2019 Q4 | 0.03 CNY | 64.5% |
| 2019 Q3 | 0.02 CNY | -52.61% |
| 2019 Q2 | 0.04 CNY | -12.27% |
| 2019 Q1 | 0.05 CNY | 108.23% |
| 2018 Q4 | 0.02 CNY | 15.5% |
| 2018 FY | - CNY | -34.62% |
| 2018 Q3 | 0.02 CNY | -63.5% |
| 2018 Q2 | 0.05 CNY | -31.5% |
| 2018 Q1 | 0.08 CNY | 35.36% |
| 2017 Q3 | 0.03 CNY | -76.92% |
| 2017 Q4 | 0.06 CNY | 97.0% |
| 2017 FY | - CNY | -18.75% |
| 2017 Q1 | 0.06 CNY | -36.51% |
| 2017 Q2 | 0.13 CNY | 116.67% |
| 2016 Q3 | 0.04 CNY | -66.67% |
| 2016 Q2 | 0.12 CNY | 103.05% |
| 2016 FY | - CNY | -48.39% |
| 2016 Q1 | 0.06 CNY | 0.0% |
| 2016 Q4 | 0.09 CNY | 136.25% |
| 2015 FY | - CNY | -98.78% |
| 2014 FY | - CNY | 10950.0% |
| 2013 FY | - CNY | 0.0% |